Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-blind Phase 1 Study to Assess the Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing

NCT00104390 is registered in ClinicalTrials.gov with Allergy Therapeutics as lead sponsor.

NCT NCT00104390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00104390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-blind Phase 1 Study to Assess the Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing
Lead sponsor
Allergy Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2005
Completion date
April 30, 2005
Enrollment
14
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type i hypersensitivity